DOLUTEGRAVIR SODIUM
sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
Molecular Identity
DOLUTEGRAVIR SODIUM
sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
PubChem CID: 46216142
Dolutegravir sodium is an organic sodium salt that is the monosodium salt of dolutegravir. Used for treatment of HIV-1. It has a role as a HIV-1 integrase inhibitor. It contains a dolutegravir(1-).
2D Structure
Properties
C20H18F2N3NaO5
Molecular Formula
441.40
Molecular Weight
g/mol
441.1112
Exact Mass
Da
102
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
836
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
DOLUTEGRAVIR SODIUM1051375-19-9Dolutegravir sodium salt1Q1V9V5WYQGSK-1349572ACHEBI:76007TIVICAY PDJULUCA COMPONENT DOLUTEGRAVIR SODIUMTRIUMEQ COMPONENT DOLUTEGRAVIR SODIUMDTXSID201027849RefChem:56965DTXCID001513426TivicayGSK1349572 sodiuM saltGSK 1349572A
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to DOLUTEGRAVIR SODIUM
Loading drug network...